We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some patients. What matters now is how we build upon that momentum.
June 03, 2026
5 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
In this Healio video, Christopher Lock, MD, discusses highlights in anti-amyloid therapies for Alzheimer’s disease presented at…
In this Healio video, Christopher Lock, MD, discusses advances in Alzheimer’s disease treatment and diagnosis presented at the…
CHICAGO — Patients with Alzheimer’s disease on amyloid-targeting therapy had less cognitive decline when their baseline amyloid…
Christopher Lock, MD, spoke with Healio about takeaways on the impact of lifestyle factors on Alzheimer’s disease presented at…
Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected…
Patients in the earliest stage of the disease saw little to no decline over four years
